The Short-term Efficacy of Gastrodia and Uncaria Drink in Treating Hypertension

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.

Also called NCT02156024

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 400 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02156024
Other papers using this trial's data
  • Persistence of Masked Hypertension in Chinese Patients American journal of hypertension, 2016-03 DOI, PubMed 26150543
  • Treatment of Masked Hypertension with a Chinese Herbal Formula: A Randomized, Placebo-Controlled Trial Circulation, 2020-11-10 DOI, PubMed 33019798

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
Not reported
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02156024. Randomized; single masking; primary purpose treatment. Start 2014-03 (registry gives no type); primary completion 2015-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Short-term Efficacy of Gastrodia and Uncaria Drink in Treating Hypertension
Condition
Masked Hypertension
Intervention (Drug)
Gastrodia and Uncaria Drink
Lead sponsor
Shanghai Institute of Hypertension (class: other)

Record details

Record id
cardio:ct-nct02156024
Content hash
4fdf648383b0569ae4771ba4dbea2c2bf07de3d0623e45aa599f01e77aa656e8